ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Integrated Machine Learning and Bioinformatic Analyses Constructed a Novel Stemness-Related Classifier to Predict Prognosis and Immunotherapy Responses for Hepatocellular Carcinoma Patients

Chen, Dongjie; Liu, Jixing; Zang, Longjun; Xiao, Tijun; Zhang, Xianlin; Li, Zheng; Zhu, Hongwei*; Gao, Wenzhe*; Yu, Xiao*海南医学院; 邵阳学院
International Journal of Biological Sciences2022DOI: 10.7150/ijbs.66913
44被引24阅读
引用收藏
分享

摘要

Immunotherapy has made great progress in hepatocellular carcinoma (HCC), yet there is still a lack of biomarkers for predicting response to it. Cancer stem cells (CSCs) are the primary cause of the tumorigenesis, metastasis, and multi-drug resistance of HCC. This study aimed to propose a novel CSCs-related cluster of HCC to predict patients' response to immunotherapy. Based on RNA-seq datasets from The Cancer Genome Atlas (TCGA) and Progenitor Cell Biology Consortium (PCBC), one-class logistic regression (OCLR) algorithm was applied to compute the stemness index (mRNAsi) of HCC patients. Unsupervised consensus clustering was performed to categorize HCC patients into two stemness subtypes which further proved to be a predictor of tumor immune microenvironment (TIME) status, immunogenomic expressions and sensitivity to neoadjuvant therapies. Finally, four machine learning algorithms (LASSO, RF, SVM-RFE and XGboost) were applied to distinguish different stemness subtypes. Thus, a five-hub-gene based classifier was constructed in TCGA and ICGC HCC datasets to predict patients' stemness subtype in a more convenient and applicable way, and this novel stemness-based classification system could facilitate the prognostic prediction and guide clinical strategies of immunotherapy and targeted therapy in HCC.

学科与关键词

关键词
Cancer stem cellImmunotherapyMachine learningHepatocellular carcinoma
相关
加载中…
  • mRNAsi-related genes can effectively distinguish hepatocellular carcinoma into new molecular subtypes
    Wang, Canbiao; Qin, Shijie; Pan, Wanwan; Shi, Xuejia; Gao, Hanyu; Jin, Ping*; Xia, Xinyi*; Ma, Fei*Computational and Structural Biotechnology Journal, 2022, 20: 2928-2941.被引 5
  • Implications of Stemness Features in 1059 Hepatocellular Carcinoma Patients from Five Cohorts: Prognosis, Treatment Response, and Identification of Potential Compounds
    Mai, Haoming; Xie, Haisheng; Luo, Mengqi; Hou, Jia; Chen, Jiaxuan; Hou, Jinlin*; Jiang, De-ke*Cancers, 2022, 14(3): 563.被引 8
  • The Association between Immune Subgroups and Gene Modules for the Clinical, Cellular, and Molecular Characteristic of Hepatocellular Carcinoma
    Chen, Wenbiao; Zhu, Peng; Xu, Huixuan; Hou, Xianliang; Guo, Changchun*Journal of Oncology, 2022, 2022: 7253876.
查看全部 →

发表信息

论文状态
公开发表
期刊
International Journal of Biological Sciences
发表日期
2022
卷期
第 18 卷, 第 1 期
页码
360-373
DOI
10.7150/ijbs.66913
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82000614, 81873589]; Natural Science Foundation of Hunan Province, China [2020JJ5876]; Science and Technology Project of Changsha, Hunan, China [kq2004146]

作者

  • C

    Chen, Dongjie (第一作者)

  • L

    Liu, Jixing

    2 · hainan med univ

查看全部 9 位作者收起作者
  • Z

    Zang, Longjun

  • X

    Xiao, Tijun

    2 · shaoyang univ

  • Z

    Zhang, Xianlin

    china three gorges univ

  • L

    Li, Zheng

    china three gorges univ

  • Z

    Zhu, Hongwei (通讯)

  • G

    Gao, Wenzhe (通讯)

  • Y

    Yu, Xiao (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417